<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pasillas MP</submitter><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><pagination>1-14</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4288246</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>Senescence is a prominent solid tumor response to therapy in which cells avoid apoptosis and instead enter into prolonged cell cycle arrest. We applied a quantitative proteomics screen to identify signals that lead to therapy-induced senescence and discovered that Bcl2-associated athanogene 3 (Bag3) is up-regulated after adriamycin treatment in MCF7 cells. Bag3 is a member of the BAG family of co-chaperones that interacts with Hsp70. Bag3 also regulates major cell-signaling pathways. Mass spectrometry analysis of the Bag3 Complex revealed a novel interaction between Bag3 and Major Vault Protein (MVP). Silencing of Bag3 or MVP shifts the cellular response to adriamycin to favor apoptosis. We demonstrate that Bag3 and MVP contribute to apoptosis resistance in therapy-induced senescence by in</pubmed_abstract><journal>Molecular &amp; cellular proteomics : MCP</journal><pubmed_title>Proteomic analysis reveals a role for Bcl2-associated athanogene 3 and major vault protein in resistance to apoptosis in senescent cells by regulating ERK1/2 activation.</pubmed_title><pmcid>PMC4288246</pmcid><funding_grant_id>P41 GM103533</funding_grant_id><funding_grant_id>R01 CA169096</funding_grant_id><pubmed_authors>Klemke R</pubmed_authors><pubmed_authors>Reilly R</pubmed_authors><pubmed_authors>Behl C</pubmed_authors><pubmed_authors>Yates JR</pubmed_authors><pubmed_authors>Pasillas MP</pubmed_authors><pubmed_authors>Gonias SL</pubmed_authors><pubmed_authors>Park R</pubmed_authors><pubmed_authors>Strnadel J</pubmed_authors><pubmed_authors>Coppinger JA</pubmed_authors><pubmed_authors>Shields S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Proteomic analysis reveals a role for Bcl2-associated athanogene 3 and major vault protein in resistance to apoptosis in senescent cells by regulating ERK1/2 activation.</name><description>Senescence is a prominent solid tumor response to therapy in which cells avoid apoptosis and instead enter into prolonged cell cycle arrest. We applied a quantitative proteomics screen to identify signals that lead to therapy-induced senescence and discovered that Bcl2-associated athanogene 3 (Bag3) is up-regulated after adriamycin treatment in MCF7 cells. Bag3 is a member of the BAG family of co-chaperones that interacts with Hsp70. Bag3 also regulates major cell-signaling pathways. Mass spectrometry analysis of the Bag3 Complex revealed a novel interaction between Bag3 and Major Vault Protein (MVP). Silencing of Bag3 or MVP shifts the cellular response to adriamycin to favor apoptosis. We demonstrate that Bag3 and MVP contribute to apoptosis resistance in therapy-induced senescence by in</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Jan</publication><modification>2026-04-30T06:12:50.784Z</modification><creation>2019-03-27T01:43:05Z</creation></dates><accession>S-EPMC4288246</accession><cross_references><pubmed>24997994</pubmed><doi>10.1074/mcp.m114.037697</doi><doi>10.1074/mcp.M114.037697</doi></cross_references></HashMap>